Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,925,000
Closed -$191M 92
2025
Q4
$191M Buy
2,925,000
+1,675,000
+134% +$134M 6.48% 3
2025
Q3
$103M Sell
1,250,000
-1,500,000
-55% -$108M 4.63% 2
2025
Q2
$181M Buy
2,750,000
+362,280
+15% +$22.6M 9.53% 1
2025
Q1
$157M Buy
2,387,720
+1,912,720
+403% +$130M 11.19% 1
2024
Q4
$36.4M Sell
475,000
-200,000
-30% -$17.3M 2.16% 17
2024
Q3
$56.4M Hold
675,000
4.27% 5
2024
Q2
$37.3M Buy
675,000
+575,000
+575% +$31.3M 2.78% 10
2024
Q1
$6.96M Buy
100,000
+40,000
+67% +$2.54M 0.58% 35
2023
Q4
$3.33M Buy
+60,000
New +$2.71M 0.35% 35

Other funds holding ACLX

Vestal Point Capital's ACLX Position: Q1 2026 in Review

Vestal Point Capital sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 2,925,000 shares — an estimated $191M sold.

Vestal Point Capital first reported a position in ACLX in Q4 2023 and held it in 9 quarters. The position peaked at $191M in Q4 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Vestal Point Capital reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • Vestal Point Capital sold 2,925,000 Arcellx shares in Q1 2026, an estimated $191M.
  • Vestal Point Capital first reported a position in Arcellx in Q4 2023 and held it in 9 quarters.
  • Vestal Point Capital's Arcellx position peaked at $191M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.